Research Funding Awards Cell and Gene Therapy
A project to develop a way to boost the effectiveness of cellular cancer therapies, led by the University of Colorado Cancer Center’s Associate Director of Cancer Research Training and Education Coordination, Eduardo Davila, PhD, is one of nine research endeavors by CU School of Medicine faculty members to be awarded major funding from the Anschutz Acceleration Initiative.
University of Colorado Cancer Center member Karolin Luger, PhD, a distinguished professor of biochemistry at CU Boulder, has been awarded the 2023 World Laureates Association (WLA) Prize in Life Science or Medicine.
University of Colorado Cancer Center member Ross Camidge, MD, PhD, has seen huge advances in lung cancer treatment during his years in the field.
The International Cytokine and Interferon Society has recognized University of Colorado Cancer Center member Edward Chuong, PhD, with its 2023 ICIS-Regeneron New Investigator Award for Excellence in Cytokine and Interferon Research.
For the past four years, University of Colorado Cancer Center member Sarah Tevis, MD, has focused her research on the psychosocial outcomes of breast surgery for women with breast cancer — specifically comparing patient-reported outcomes three and six months after receiving a lumpectomy (surgery in which just the tumor and some of the surrounding cells are removed) and a mastectomy (surgery to remove the entire breast).
The good news for people with multiple myeloma is that treatments exist that almost always put the cancer into deep remission soon after it’s diagnosed. The bad news for people with the blood cancer, though, is that even though that remission can last several years, almost all patients eventually relapse — and the disease that returns becomes increasingly difficult to treat.
Research Surgical Oncology Awards
For her innovative research on how cannabinoids affect the tumor immune microenvironment in melanoma, University of Colorado Cancer Center member Camille Stewart, MD, has been named to the 2023 cohort of the National Cancer Institute’s Early-Stage Surgeon Scientist Program (ESSP). The National Cancer Institute coordinates the United States National Cancer Program and is part of the National Institutes of Health (NIH).
Channing E. Tate, PhD, MPH, University of Colorado Cancer Center Rising Star, has seen through her personal and professional experiences how aging populations and communities of color often fall through the cracks of health care, especially at the end of life.
University of Colorado Cancer Center member Bryan Haugen, MD, always knew he was a science person. His question was if he wanted to be a MD or a PhD. After completing his bachelor’s degree at Saint Olaf College in Minnesota, he did a few years of research at the Mayo Clinic before starting medical school there.
Gripped
March 27, 2024
Just 18 months after his leukemia diagnosis and on the brink of a bone marrow transplant, Chen defied the odds with an inspiring ascent. Reflecting on his journey, Chen's resilience shines through as he remains optimistic and determined for the future.
EurekAlert
March 06, 2024
Researchers at the University of Colorado Anschutz Medical Campus found that drugs like botox may slow head and neck cancer progression by targeting nerve interactions in tumor environments, impacting immune responses. This study could lead to new treatments for patients intolerant to traditional therapies.
Mile High Magazine
February 25, 2024
Christopher Lieu, MD speaks on March being Colorectal Cancer Awareness Month and the importance of screening.
National Institutes of Health (NIH)
February 21, 2024
In 2024, the network will launch a pilot study, known as the Vanguard Study on Multi-Cancer Detection, to address the feasibility of using multi-cancer detection (MCD) tests in future randomized controlled trials.
Mark Harden
